logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

CeftazidimeAcquired drug resistance: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2025年 / 2042卷 / 1期
关键词:
D O I:
10.1007/s40278-025-74910-8
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:111 / 111
相关论文
共 50 条
  • [41] GefitinibAcquired drug resistance: case report
    Reactions Weekly, 2021, 1866 (1) : 187 - 187
  • [42] TemozolomideHypermutagenesis and drug resistance: case report
    Reactions Weekly, 2021, 1851 (1) : 341 - 341
  • [43] InfliximabDevelopment of drug resistance: case report
    Reactions Weekly, 2021, 1847 (1) : 244 - 244
  • [44] BedaquilineEmergence of drug resistance: case report
    Reactions Weekly, 2019, 1777 (1) : 52 - 52
  • [45] CrizotinibDevelopment of drug resistance: case report
    Reactions Weekly, 2021, 1882 (1) : 158 - 158
  • [46] CrizotinibDevelopment of drug resistance: case report
    Reactions Weekly, 2018, 1705 (1) : 104 - 104
  • [47] EmicizumabDevelopment of drug resistance: case report
    Reactions Weekly, 2022, 1888 (1) : 165 - 165
  • [48] ImatinibThrombocytopenia and drug resistance: case report
    Reactions Weekly, 2010, 1310 (1) : 28 - 28
  • [49] BlinatumomabDevelopment of drug resistance: case report
    Reactions Weekly, 2021, 1847 (1) : 101 - 101
  • [50] MeropenemDevelopment of drug resistance: case report
    Reactions Weekly, 2020, 1785 (1) : 329 - 329
← 12345 →